Skip to main content
. 2022 Nov 8;13:1035359. doi: 10.3389/fmicb.2022.1035359

Table 1.

Demographic and clinical characteristics of the patients.

Item Total (n = 63) Asymptomatic (n = 14) Mild infection (n = 49) (%) p-valuea
Age (mean ± SD), years 47.71 ± 15.21 50.86 ± 16.28 46.82 ± 14.94 0.385
Status of menopause, n (%) Postmenopausal 25(39.7) 7(50.0) 18(36.7) 0.371
Reproductive-aged 38(60.3) 7(50.0) 31(63.3)
Vaccination, n (%) Vaccination (2–3 shots) 43(68.3) 8(57.1) 35(71.4) 0.492
Unvaccinated or one shot 20(31.7) 6(42.9) 14(28.6)
Underlying diseases status, n (%) 0.240
None 49(77.8) 13 (92.9) 36 (73.5)
Combined underlying diseases 14(22.2) 1(7.1) 13(26.5)
Chronic hypertension, n (%) 8(12.7) 0(0.0) 8 (16.3) 0.245
DM2, n (%) 5(7.9) 0(0.0) 5 (10.2) 0.578c
Others, (%) 5(7.9) 1(7.1) 4 (8.2) 0.258c
anal swabs, n (%) 4(6.5) 0(0.0) 4(8.3) 0.566c
Hospitalization (mean ± SD),days 16.73 ± 3.16 15.79 ± 3.47 17.00 ± 3.06 0.208b
Interval between infectiononset and sampling (mean ± SD), days 11.25 ± 2.23 11.14 ± 2.51 11.29 ± 2.17 0.834b

achi-square test, bindependent-sample t test, cFisher exact test.